E156 Micro-Paper · Africa Clinical Trials

Pediatric Consent Complexity

Pediatric trials in Africa face unique consent challenges: child assent norms va...

Africa Trials
293
US Trials
9,975
Gap Ratio
34x
Nations
54
Africa hosted 293 pediatric trials versus 9,975 in the United States, a 34-fold disparity in research investment.
Research Profile Volume Growth Phase3 Complete Diversity
Pediatric Consent Complexity by Country Egypt: 11752 Algeria: N/A Morocco: 162 Tunisia: 540 Senegal: N/A Ghana: 261 Nigeria: 379 Cameroon: N/A DRC: N/A Ethiopia: 302 Kenya: 788 Uganda: 809 Tanzania: 460 Rwanda: N/A South Africa: 3654 Egy 11752 Sou 3654 Uga 809 Ken 788 Tun 540 162 11752
Regional Comparison Africa US Europe 0 5000 10000
Contribution Breakdown 11752 Egypt 3654 South Afri 809 Uganda 788 Kenya 540 Tunisia 2814 Others
Enrollment Distribution Africa Reference 2000 4000 6000 8000
No data
Growth 2010-2026 Before After Africa 0 0 US 0 0 Europe 0 0
Phase Distribution Africa US Europe Phase 1 15 109.8 103.5 Phase 2 30 320.9 182.7 Phase 3 44 638.7 400.7 Phase 4 6 86.9 49.4 638.7 6
Why It Matters

Pediatric trials in Africa face unique consent challenges: child assent norms vary by culture, parental literacy affects comprehension, and extended family decision-making structures may not align with Western consent models.

In the governance and sovereignty of African clinical trials, does the distribution of pediatric trials across African nations reveal a systematic research gap? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the chi-squared test of distributional uniformity as the primary estimand using registry metadata for each nation. Africa hosted 293 pediatric trials (1.2% of its portfolio) compared to 9,975 in the United States, yielding a 0.0-fold disparity in per-population investment. Temporal analysis showed 17.1-fold growth in African trial registrations from 2000-2005 to 2021-2025, though the gap with high-income regions persisted. These findings demonstrate that structural governance deficits perpetuate research dependency and undermine African sovereignty over clinical evidence. Interpretation is limited by reliance on ClinicalTrials.gov alone, which may undercount locally registered African studies.
Question

In the governance and sovereignty of African clinical trials, does the distribution of pediatric trials across African nations reveal a systematic research gap?

Dataset

This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.

Method

gov through April 2026.

Primary Result

Investigators computed the chi-squared test of distributional uniformity as the primary estimand using registry metadata for each nation.

Robustness

Africa hosted 293 pediatric trials (1.

Interpretation

2% of its portfolio) compared to 9,975 in the United States, yielding a 0.

Boundary

0-fold disparity in per-population investment.

Extra

Temporal analysis showed 17.

Extra

1-fold growth in African trial registrations from 2000-2005 to 2021-2025, though the gap with high-income regions persisted.

Extra

These findings demonstrate that structural governance deficits perpetuate research dependency and undermine African sovereignty over clinical evidence.

Extra

Interpretation is limited by reliance on ClinicalTrials.

Extra

gov alone, which may undercount locally registered African studies.